The largest database of trusted experimental protocols

14 protocols using sclerostin

1

Serum FGF-23 and Sclerostin Measurement

Check if the same lab product or an alternative is used in the 5 most similar protocols
Commercially available ELISA kits for FGF-23 (Kainos Laboratories Inc, Tokyo, Japan; intraassay and interassay CV, <2.8% and <3.8%, respectively) and sclerostin (R&D Systems, Minneapolis, MN, USA; intraassay and interassay CV, <2.1% and <10.8%, respectively) were applied for measurement of serum FGF-23 and sclerostin.
+ Open protocol
+ Expand
2

Western Blotting of Cellular Extracts

Check if the same lab product or an alternative is used in the 5 most similar protocols
Western blotting of whole-cell extracts isolated from cells in culture after FSS or extracts isolated from murine long bone was done as previously described (68 (link), 70 (link)). Equal amounts of protein were loaded and electrophoresed on 10% SDS–polyacrylamide gel electrophoresis gels and transferred to polyvinylidene difluoride membranes. Membranes were blocked in 5% nonfat dry milk (unless otherwise stated) and probed with the indicated primary antibodies overnight at 4°C. Antibodies were detected with the appropriate horseradish peroxidase–conjugated secondary antibodies (Cell Signaling Technology) and enhanced chemiluminescence detection reagent (Bio-Rad). The antibodies used were sclerostin (R&D Systems, AF1589), α-tubulin (Sigma, T9026), detyrosinated tubulin (Abcam, ab48389), phospho-CamKII Thr286 (Cell Signaling Technology, 12716S), total CaMKII (Cell Signaling Technology, 11945S), and GAPDH (Millipore, MAB374). Blots were acquired using an EpiChem gel documentation system (UVP Bioimaging Systems) and analyzed using ImageJ software.
+ Open protocol
+ Expand
3

Fracture Healing Progression Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
We harvested fractured tibiae at 7, 10, and 14 days. Subsequently, we fixed the tissues in 10% formalin for 24 hr and decalcified in 10% EDTA at pH 7.2 for 2 weeks. The samples were processed, embedded in paraffin, and cut into 3-μm sagittal sections. Then, we stained three contiguous sections (100 μm apart) from each specimen with Alcian Blue/Hematoxylin/Orange G (ABH) according to standard protocols.
We conducted quantitative analysis on the sagittal ABH/OG-stained sections by histomorphometric analysis using Osteometrics software. Parameters included the areas of woven bone, cartilage, and total fracture callus, and calculated the amount of mesenchymal tissue by subtracting bone and cartilage area from the total callus area. We expressed bone, cartilage, and mesenchymal tissue areas each as a percentage of the total fracture calluses. Sections were stained with a polyclonal anti-mouse antibody specific for β-catenin (1:50, Cell Signaling Technologies, Danvers, MA) or sclerostin (1:100; R&D Systems), or matched isotype control antibody. The primary antibody was visualized with an HRP-conjugated rabbit anti-goat antibody (Jackson ImmunoResearch Laboratories). Sections were counterstained with hematoxylin.
+ Open protocol
+ Expand
4

Modulating Osteoblast Differentiation

Check if the same lab product or an alternative is used in the 5 most similar protocols
All drug treatments were carried out in serum free DMEM/F12 for 24 hours. TGFβ and Sclerostin (R&D Systems) were used at 10ng/ml and 1-2ug/ml respectively. TGFβ buffer (5%BSA in 4mmol HCl) was used as a control. GANT58 and Lithium Chloride (Sigma-Aldrich) were used at 10μM and 20mM respectively. Purmorphamine and SIS3 (EMD Millipore) were used at 10μM. Cyclopamine (LC Labs) was used at 12nM. SB202190 (Tocris) was used at 10μM. VU-WS113, a less cytotoxic derivative of Pyrvinium, was a gift from Dr. Ethan Lee at Vanderbilt University.
+ Open protocol
+ Expand
5

Quantifying M-CSF, Sclerostin, and DKK1

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human Quantikine M-CSF, Sclerostin, and DKK1 ELISA kits (R&D Systems, Minneapolis, MN, USA) were used to quantify M-CSF, Sclerostin, and DKK1, respectively, in the cell supernatants according to the manufacturer’s instructions.
+ Open protocol
+ Expand
6

Serum Biomarker Measurements in Longitudinal Study

Check if the same lab product or an alternative is used in the 5 most similar protocols
Serum samples were collected at baseline and the 12-month visit. An immunochemiluminometric assay was used to measure 17β-estradiol (LabCorp Esoteric Testing, Burlington, NC, sensitivity 25.0 pg/mL; intra-assay coefficient of variation 1.2% to 6.7%). Serum Pref-1 concentrations were measured by a sandwich enzyme-linked immunosorbent assay (ELISA) assay (R&D Systems, Inc., Minneapolis, MN; intra-assay coefficient of variation 3.7%, inter-assay coefficient of variation 6.2%; sensitivity 0.012 ng/ml). An enzyme-linked immunosorbent assay was used to measure sclerostin (R&D Systems, Minneapolis, MN; sensitivity 1.74 pg/mL; intra-assay CV 2%).
+ Open protocol
+ Expand
7

Immunohistochemical Analysis of Wnt Antagonists

Check if the same lab product or an alternative is used in the 5 most similar protocols
Sections in groups of three to five were placed on SuperFrost positive charged (Fisher Scientific) slides and dried for 3 hours at 58°C. Paraffin was removed by a sequential dips in xylene and rehydrated through graded washes of ethanol and water, and finally washed in 1X PBS. Sections were incubated in blocking solution (2.5% BSA, 1% donkey serum in PBS) overnight at 4 C. The following day, sections were incubated with primary antibody against: Sclerostin (R&D System Minneapolis, MN), Dkk1 (Abcam; Cambridge, MA), Dkk2 (R&D System; Minneapolis, MN), Dkk3 and Dkk4 (Santa Cruz Biotechnology; Santa Cruz, CA) at a 1:100 dilution for 4 hours at room temperature for Sclerostin and overnight at 4 °C for Dkk1, 2, 3 and 4, followed by three washes for 5 minutes each wash. Then sections were incubated for 1 hour with Cy3 conjugated Donkey anti goat (or anti-rabbit) secondary antibody (Jackson ImmunoResearch Laboratories, West Grove, PA) (1:200 in blocking solution) and DAPI. Isotype matched non-immune IgG are used as a negative control for all immunostaining studies.
+ Open protocol
+ Expand
8

Regulation of Sclerostin and TGF-β Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lithium chloride solution (LiCl, 8M solution; Sigma-Aldrich, St. Louis, MO) was added at a final concentration of 20mM [21 , 22 (link)] or 40mM [21 ] to serum-free DMEM for 24 hours. Sclerostin (R&D Systems) was added at a final concentration of 1.5 µg/ml to DMEM or HS5 culture medium as indicated in the figure legends and incubated for 24 hours, then conditioned medium was removed and transferred to MDA-MB-231 cells for 24 hour incubation prior to RNA harvest. 2G7, a TGF-β neutralizing monoclonal antibody (provided by the Vanderbilt Antibody Core), or control IgG 12CA5 were administered in vitro at 10µg/ml using the same method as Sclerostin treatment.
+ Open protocol
+ Expand
9

Quantification of Ankle and Serum Sclerostin and SFRP1

Check if the same lab product or an alternative is used in the 5 most similar protocols
After chloroform separation, the protein fraction was purified with isopropanol, chlorhydrate guanidine, and ethanol. After ultrasound exposure, samples were homogenised in 1% SDS and stored with protease inhibitors. Quantification of total proteins was performed with Pierce BCA protein assay (Thermo Scientific). Sclerostin (R&D systems, Minneapolis, MN, US) and SFRP1 protein (Cusabio, College Park, MD, US) were quantified at the ankle site and in the serum by using antibody-based detection assays (R&D systems, Minneapolis, MN, US (R&D systems, Minneapolis, MN, US and Cusabio, College Park, MD, US, respectively).
+ Open protocol
+ Expand
10

Kidney Disease Biomarker Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood was collected from rats on days 19 and 26 post-nephrectomy. Serum was stored at − 80 °C for future quantitation of intact FGF23 (EMD Millipore, Temecula, CA), phosphorus (Biovision Inc., Milpitas, CA), sclerostin (R&D Systems, Minneapolis, MN), calcium (Fisher Scientific, Hampton, NH), creatinine (Biovision Inc., Milpitas, CA), and intact PTH (iPTH) (Fisher Scientific, Hampton, NH) with ELISA kits. ELISAs were performed according to manufacturers’ recommended instructions.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!